Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Aetna Inc    AET

Delayed Quote. Delayed  - 10/24 10:00:32 pm
112.02 USD   +0.69%
10/24 BUYINS.NET : WTBA, AET, TK, SLAB Expected To Be Up Before Next Earni..
10/24 AETNA : FIDO Alliance Announces New Authentication Specification Eff..
10/18DJZenefits Touts New Software in Turnaround Effort
News SummaryMost relevantAll newsSector news 

Aetna Profit Declines As Health-Care Costs Rebound

share with twitter share with LinkedIn share with facebook
share via e-mail
04/26/2012 | 10:53pm CEST

--Aetna earnings decline, missing analyst expectations

--Insurer didn't benefit from surplus money set aside to pay claims, as it did a year ago

--Company reiterates full-year guidance

(Adds company comments regarding expected cost trends and reserve assumptions. Adds closing stock price.)

   By Jon Kamp 

Aetna Inc.'s (>> Aetna Inc.) first-quarter earnings declined 13%, falling short of Wall Street expectations, after the insurer found it didn't have a surplus in money set aside to cover earlier patient claims, a possible indication patients are making more doctors visits after a long slump.

Aetna and other insurers establish reserves to cover claims for the current period and prior ones. If those reserves wind up too high, as has been the trend with patients lightly using health-care services, the extra money is added to earnings.

In the first quarter, the money Aetna set aside for fourth-quarter claims turned out to be more on target, leaving less money to add to the bottom line. Aetna pegged the lack of extra money to stabilizing medical costs late last year, but was hesitant to suggest usage trends are significantly changing.

Everybody is "sort of feeling for the bottom here where a trend stops decelerating and starts to tick up," said Mark Bertolini, Aetna's chairman and chief executive, on a call with analysts.

The company on Thursday maintained its forecast for an uptick in health-system usage this year. A spokeswoman said Aetna is comfortable with its reserve assumptions for the first quarter based on its expectation for rising costs. Chief Financial Officer Joseph Zubretsky said on the call that Aetna has made "prudent assumptions regarding medical cost trends for 2012."

Still, the disappointing results spooked investors, who sent Aetna shares plunging, down 8.2% to $45.31. The news also weighed on some other insurers, as UnitedHealth Group Inc. (UNH) slipped 0.9% to $58.37, and Cigna Inc. (>> CIGNA Corporation) declined 1.4% to $47.56.

There could be broader implications, as Goldman Sachs analyst Matthew Borsch said the pressure on margins seen at Aetna "reflects industry trends more than company-specific issues." This pressure comes from a mix of modestly increasing medical cost trends and intensifying price competition, the analyst said.

Health-care observers have been watching for an acceleration in medical usage after a long period of patients avoiding visits to doctors' offices and hospitals because of the still-uncertain economy. Recent signals from around the health-care sector have been mixed, with signs of higher spending coming from some corners, such as among replacement-joint manufacturers.

CFO Zubretsky said Aetna's results reflect "the stabilizing medical cost trend we observed in the fourth quarter." He noted that earlier last year, trends that reflect a mix of health costs and how much patients use the system decreased significantly below Aetna's expectations, leading to positive reserves.

In an interview, Zubretsky added that the company isn't saying this cost trend picked up in the fourth quarter. Rather, "I would say it stopped decelerating," he said.

Aetna said its total medical-benefit ratio--or the amount of premiums used to pay patient medical costs--rose to 81.5% in the first quarter, from 79.2% a year earlier and 80.7% in the prior quarter.

The ratio was pushed lower last year by the fact Aetna set aside more money than it wound up needing to pay claims. "There was no significant prior-years reserve development in the first quarter of 2012," Aetna said Thursday.

Overall, Aetna reported a first-quarter profit of $511 million, or $1.43 a share, down from $586 million, or $1.50 a share, a year earlier. Operating earnings in the latest period were $1.34 a share.

Revenue excluding capital gains and losses increased 6.2% to $8.86 billion, mostly owing to higher health-care premiums and fees. Analysts polled by Thomson Reuters had projected earnings of $1.40 a share on revenue of $8.69 billion.

After the strong results from other insurers, "and the market's optimistic assumptions about where Aetna's guidance could go, it's hard to see how this quarter isn't viewed as a disappointment," Citigroup analyst Carl McDonald said.

Despite the light first-quarter earnings, the company reiterated its guidance for full-year operating earnings of about $5 a share, while saying it expects to boost membership over the year after a first-quarter decline.

Aetna ended the first quarter with about 17.9 million medical members, a decline of 544,000 from the fourth quarter, reflecting an expected decrease in the company's commercial business and the company's exit from Connecticut's Medicaid program. Bertolini said Aetna expects to grow to 18.2 million medical members over the course of this year.

"We're seeing positive momentum in our 2013 selling season with early National Accounts wins and new business opportunities that are twice what they were a year ago," the CEO said.

-By Jon Kamp, Dow Jones Newswires; 617-654-6728; jon.kamp@dowjones.com

Order free Annual Report for Aetna, Inc.

Visit http://djnweurope.ar.wilink.com/?ticker=US00817Y1082 or call +44 (0)208 391 6028

Order free Annual Report for CIGNA Corp.

Visit http://djnweurope.ar.wilink.com/?ticker=US1255091092 or call +44 (0)208 391 6028

Order free Annual Report for UnitedHealth Group, Inc.

Visit http://djnweurope.ar.wilink.com/?ticker=US91324P1021 or call +44 (0)208 391 6028

Stocks mentioned in the article : Aetna Inc., CIGNA Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on AETNA INC
10/24 BUYINS.NET : WTBA, AET, TK, SLAB Expected To Be Up Before Next Earnings Releases
10/24 AETNA : FIDO Alliance Announces New Authentication Specification Effort with EMV..
10/18DJZenefits Touts New Software in Turnaround Effort
10/18 UnitedHealth sees more growth in 2017 when it exits Obamacare
10/13 AETNA : to Announce Third-Quarter 2016 Results
10/13 AETNA INC (NYSE : AET), Merck & Co., Inc. (NYSE:MRK) Sign Value-Based Partnershi..
10/13 REGIONAL CANCER CARE ASSOCIATES : And Aetna Form Oncology Medical Home
10/12 AETNA : ’s Stars Are Shining as CMS Announces Medicare Quality Ratings
10/12DJHUMANA : Sees Potential Fallout From Lower Medicare Star-Rating Report
10/11 AETNA : and Merck Sign a Unique Value-Based Contract for Januvia® and Janumet®
More news
Sector news : Managed Healthcare - NEC
10/21DJCIGNA : Ends Preauthorization for Medication to Treat Opioid Addiction
10/18DJUNITEDHEALTH : Tops Views, Boosts Outlook
10/18 UnitedHealth sees more growth in 2017 when it exits Obamacare
10/18 UNITEDHEALTH : CEO sees earnings growth continuing into 2017
10/12DJHUMANA : Sees Potential Fallout From Lower Medicare Star-Rating Report--3rd Upda..
More sector news : Managed Healthcare - NEC
News from SeekingAlpha
02:22a Obamacare rates up 25% in 2017
10/17 Health Insurance Companies To Hike Prices Now, Suffer Later
10/01 Dividend Champions For October 2016
09/30 Aetna declares $0.25 dividend
09/29 AETNA SUBSIDIZING APPLE WATCH : Fitbit gets downgrade
Financials ($)
Sales 2016 63 240 M
EBIT 2016 4 945 M
Net income 2016 2 583 M
Debt 2016 4 521 M
Yield 2016 0,90%
P/E ratio 2016 15,31
P/E ratio 2017 13,63
EV / Sales 2016 0,69x
EV / Sales 2017 0,65x
Capitalization 39 297 M
More Financials
Duration : Period :
Aetna Inc Technical Analysis Chart | AET | US00817Y1082 | 4-Traders
Full-screen chart
Technical analysis trends AETNA INC
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 137 $
Spread / Average Target 22%
Consensus details
EPS Revisions
More Estimates Revisions
Mark T. Bertolini Chairman & Chief Executive Officer
Karen S. Lynch President
Margaret M. McCarthy Executive Vice President-Operations & Technology
Shawn M. Guertin CFO, Executive VP & Chief Enterprise Risk Officer
Harold L. Paz Chief Medical Officer & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AETNA INC3.61%39 297
ANTHEM INC-10.72%32 762
HUMANA INC-1.25%26 276
CENTENE CORP-4.19%10 765
More Results